| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8218837 | International Journal of Radiation Oncology*Biology*Physics | 2014 | 9 Pages |
Abstract
The EGFRvIII mutation is not present in HNSCC. Therefore, EGFRvIII does not influence treatment response in HNSCC and is not a usable clinical prognostic marker.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Lieuwe J. MD, PhD, Martijn J.A.M. MSc, Mirjam F. BSc, Lorian BSc, Johannes A. MD, PhD, Bernard F.A.M. MD, PhD, Jacqueline E. MD, DDS, PhD, Bert MD, PhD, Jan L.N. DDS, PhD, Ed PhD,